KUALA LUMPUR, Oct 23 (Bernama) -- Fortrea, a global contract research organisation, has partnered with Omico, an Australian oncology screening and trial matching organisation, to help connect cancer patients with clinical trials matched to the genetic profile of their tumours.
General : Fortrea, Omico To Match Australian Cancer Patients With Trials
Fortrea, Omico To Match Australian Cancer Patients
BE Bernama 
Key takeaways
Fortrea partners with Omico to connect Australian cancer patients with trials based on tumor genetics.
- Fortrea and Omico collaborate to match cancer patients with clinical trials using genetic profiles.
- The partnership aims to improve trial planning and patient recruitment in Australia.
- Omico provides genomic data and trial matching to Fortrea's global network.
Summarised automatically by AI from the original article by Bernama. AI can make mistakes, so check the original for details.
Read the full story on Bernama That's the opening of the story. The full piece is published by Bernama.
Continue reading ↗ Story details
- Published
- Section
- news
- Format
- Article
- Original
- bernama.com ↗
Topics
%2Ffile%2Fattachments%2Forphans%2F453234432234324_895682.png&w=480&output=webp&q=85&we)